Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Geranium Wilfordii with ADT in Neoadjuvant Prostate Cancer
NCT06861166Phase 3Not yet recruiting
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- NHE (Natural Herbal Extract), Decoction
01
Overview
A Phase 3 trial of geranium wilfordii in prostate cancer (PCa). Planned start Mar 2025; status: not yet recruiting.
02
Drugs
geranium wilfordii
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06861166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06861166.